Scott Rice, DO
Emergency Medicine · Columbia, SCNPI 1063038149
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Lilly USA, LLC at 58.8% of the total. Reporting peaked in 2024 at $256 and has fallen 89.7% since, to $26 in 2025. Among emergency medicine clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$258
- Dexcom, Inc.$81
- Boston Scientific$26
- VBI Vaccine (delaware) Inc.$22
- AstraZeneca$20
- Merck$18
- plus $14 from 1 others
What the payments were for
- Food & beverage$438100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 15 | $258 |
| Dexcom, Inc. | 3 | $81 |
| Boston Scientific | 1 | $26 |
| VBI Vaccine (delaware) Inc. | 1 | $22 |
| AstraZeneca | 1 | $20 |
| Merck | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $14 |
How this compares
$438 in reported general payments places this provider in the 90th percentile of 1,024 emergency medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 18 | $338 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $215 |
| Cephalexin | 17 | $120 |
| Doxycycline Hyclate | 15 | $97 |
| Prednisone | 24 | $48 |
| Ondansetron OdtOndansetron | 12 | $43 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $28 |
| Potassium Chloride | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Columbia
- Heather BrownColumbia$123K
- Daniel TrohaColumbia$29K
- Thomas CookColumbia$14K
- Andrew DonatoColumbia$2K
- Courtney LaneColumbia$982
- Louis LeblancColumbia$788
- Wesley CarterColumbia$624
- Christopher MichaelisMount Pleasant$399K
- Phillip MoschellaGreenville$298K
- Gregory HallCharleston$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.